Published in J Chem Inf Comput Sci on June 18, 2001
The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell (1993) 4.30
Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity (1994) 3.73
Immune regulation by CD40 and its ligand GP39. Annu Rev Immunol (1996) 3.56
The x-ray structure of an anti-tumour antibody in complex with antigen. Nat Struct Biol (1995) 1.76
The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association. Immunity (1995) 1.63
The structure of copper-nitrite reductase from Achromobacter cycloclastes at five pH values, with NO2- bound and with type II copper depleted. J Biol Chem (1995) 1.54
Characterization of mouse ALCAM (CD166): the CD6-binding domain is conserved in different homologs and mediates cross-species binding. Eur J Immunol (1997) 1.22
Extending the B7 (CD80) gene family. Protein Sci (1994) 1.22
Covalent dimerization of CD28/CTLA-4 and oligomerization of CD80/CD86 regulate T cell costimulatory interactions. J Biol Chem (1996) 1.21
Complementarity determining region 1 (CDR1)- and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1. J Exp Med (1994) 1.20
CD6-ligand interactions: a paradigm for SRCR domain function? Immunol Today (1997) 1.10
Solution structure of human CTLA-4 and delineation of a CD80/CD86 binding site conserved in CD28. Nat Struct Biol (1997) 1.04
Both extracellular immunoglobin-like domains of CD80 contain residues critical for binding T cell surface receptors CTLA-4 and CD28. J Biol Chem (1995) 1.03
The amino-terminal immunoglobulin-like domain of activated leukocyte cell adhesion molecule binds specifically to the membrane-proximal scavenger receptor cysteine-rich domain of CD6 with a 1:1 stoichiometry. J Biol Chem (1996) 1.02
X-ray and model-building studies on the specificity of the active site of proteinase K. Proteins (1988) 1.00
Binding stoichiometry of the cytotoxic T lymphocyte-associated molecule-4 (CTLA-4). A disulfide-linked homodimer binds two CD86 molecules. J Biol Chem (1995) 0.99
Escherichia coli and Porphyromonas gingivalis lipopolysaccharide interactions with CD14: implications for myeloid and nonmyeloid cell activation. Clin Infect Dis (1999) 0.96
Site-specific recognition by an isolated DNA-binding domain of the sine oculis protein. Biochemistry (1997) 0.94
Molecular descriptors in chemoinformatics, computational combinatorial chemistry, and virtual screening. Comb Chem High Throughput Screen (2000) 0.94
Chimeric L6 anti-tumor antibody. Genomic construction, expression, and characterization of the antigen binding site. J Biol Chem (1992) 0.92
Similarity between fluorescein-specific T-cell receptor and antibody in chemical details of antigen recognition. Proc Natl Acad Sci U S A (1992) 0.91
Interaction of P-selectin (CD62) and its cellular ligand: analysis of critical residues. Biochemistry (1993) 0.91
Identification of amino acid residues important for ligand binding to Fas. J Exp Med (1997) 0.89
Affinity maturation of the BR96 anti-carcinoma antibody by codon-based mutagenesis. J Immunol (1995) 0.89
Mutational analysis of the CD6 binding site in activated leukocyte cell adhesion molecule. Biochemistry (1996) 0.88
Cell surface receptors and their ligands: in vitro analysis of CD6-CD166 interactions. Proteins (2000) 0.88
Analysis of 4-1BBL and laminin binding to murine 4-1BB, a member of the tumor necrosis factor receptor superfamily, and comparison with human 4-1BB. J Biol Chem (1997) 0.88
Inhibition of proteinase K by methoxysuccinyl-Ala-Ala-Pro-Ala-chloromethyl ketone. An x-ray study at 2.2-A resolution. J Biol Chem (1991) 0.88
Identification of CD14 residues involved in specific lipopolysaccharide recognition. Infect Immun (1997) 0.88
Single-chain mono- and bispecific antibody derivatives with novel biological properties and antitumour activity from a COS cell transient expression system. Ther Immunol (1994) 0.87
Membrane topology of the L6 antigen and identification of the protein epitope recognized by the L6 monoclonal antibody. J Biol Chem (1994) 0.87
Identification of residues in CD6 which are critical for ligand binding. Biochemistry (1997) 0.85
X-ray structure of the uncomplexed anti-tumor antibody BR96 and comparison with its antigen-bound form. J Mol Biol (1996) 0.84
Shannon entropy--a novel concept in molecular descriptor and diversity analysis. J Mol Graph Model (2000) 0.83
Comparison of CH1 domains in different classes of murine antibodies. J Mol Biol (1996) 0.82
Binary quantitative structure-activity relationship (QSAR) analysis of estrogen receptor ligands. J Chem Inf Comput Sci (1999) 0.82
A combinatorial library strategy for the rapid humanization of anticarcinoma BR96 Fab. J Biol Chem (1996) 0.82
Differential Shannon Entropy as a sensitive measure of differences in database variability of molecular descriptors. J Chem Inf Comput Sci (2001) 0.82
Specific binding of Fyn and phosphatidylinositol 3-kinase to the B cell surface glycoprotein CD19 through their src homology 2 domains. Eur J Immunol (1995) 0.81
Distinguishing between natural products and synthetic molecules by descriptor Shannon entropy analysis and binary QSAR calculations. J Chem Inf Comput Sci (2000) 0.81
Sulfated galactocerebrosides as potential antiinflammatory agents. J Med Chem (1997) 0.80
Database searching for compounds with similar biological activity using short binary bit string representations of molecules. J Chem Inf Comput Sci (1999) 0.80
Mutational analysis of the CD6 ligand binding domain. Protein Eng (1997) 0.79
BMS-190394, a selectin inhibitor, prevents rat cutaneous inflammatory reactions. J Pharmacol Exp Ther (1997) 0.79
Molecular descriptors for effective classification of biologically active compounds based on principal component analysis identified by a genetic algorithm. J Chem Inf Comput Sci (2000) 0.79
Molecular scaffold-based design and comparison of combinatorial libraries focused on the ATP-binding site of protein kinases. J Mol Graph Model (1999) 0.79
Evaluation of descriptors and mini-fingerprints for the identification of molecules with similar activity. J Chem Inf Comput Sci (2000) 0.79
Computational biochemistry of antibodies and T-cell receptors. Adv Protein Chem (1996) 0.78
Mini-fingerprints detect similar activity of receptor ligands previously recognized only by three-dimensional pharmacophore-based methods. J Chem Inf Comput Sci (2001) 0.78
Cloning of the murine counterpart of the tumor-associated antigen H-L6: epitope mapping of the human and murine L6 antigens. Biochemistry (1995) 0.78
Searching for molecules with similar biological activity: analysis by fingerprint profiling. Pac Symp Biocomput (2000) 0.77
Analysis of the ligand binding site in Fas (CD95) by site-directed mutagenesis and comparison with TNFR and CD40. Biochemistry (1998) 0.77
Humanization of 60.3, an anti-CD18 antibody; importance of the L2 loop. Protein Eng (1994) 0.77
Recognition of diverse proteins by members of the immunoglobulin superfamily: delineation of the receptor binding site in the human CD6 ligand ALCAM. Biochemistry (1996) 0.76
Modifying the specificity and activity of the Enterobacter cloacae P99 beta-lactamase by mutagenesis within an M13 phage vector. Biochemistry (1996) 0.76
CD6 recognizes the neural adhesion molecule BEN. Protein Sci (1997) 0.76
Profiles for the analysis of immunoglobulin sequences: comparison of V gene subgroups. Protein Sci (1995) 0.75
Evaluation of docking strategies for virtual screening of compound databases: cAMP-dependent serine/threonine kinase as an example. J Mol Graph Model (1998) 0.75
Crystallization and preliminary X-ray analysis of the monoclonal anti-tumor antibody BR96 and its complex with the Lewis Y determinant. J Mol Biol (1994) 0.75
CD28/CTLA-4 receptor structure, binding stoichiometry and aggregation during T-cell activation. Res Immunol (1996) 0.75
Protein superfamily members as targets for computer modeling: the carbohydrate recognition domain of a macrophage lectin. Pac Symp Biocomput (1997) 0.75
Mini-fingerprints for virtual screening: design principles and generation of novel prototypes based on information theory. SAR QSAR Environ Res (2003) 0.75
Identification of residues in the monoclonal antitumor antibody L6 important for binding to its tumor antigen. Biochemistry (1994) 0.75
Computational techniques for diversity analysis and compound classification. Mini Rev Med Chem (2004) 0.75
Analysis of BR96 binding sites for antigen and anti-idiotype by codon-based scanning mutagenesis. J Immunol (1998) 0.75
Comparison of binary and 2D QSAR analyses using inhibitors of human carbonic anhydrase II as a test case. Mol Divers (1999) 0.75